• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VITAL ACCESS CORP. VWING VASCULAR NEEDLE GUIDE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VITAL ACCESS CORP. VWING VASCULAR NEEDLE GUIDE Back to Search Results
Model Number 00145
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Wound Dehiscence (1154); Hearing Impairment (1881); Necrosis (1971); Pocket Erosion (2013); Post Operative Wound Infection (2446)
Event Date 02/09/2016
Event Type  Injury  
Manufacturer Narrative
The physician explained that the patient had experienced problems with poorly-healing skin in the past ('crappy skin').While the vwing itself is not likely to be the cause of this patient's site dehiscence, we cannot rule out any relationship between the device and the adverse event.While two vwing devices were explanted when the patient's fistula was excised, only a single site had dehisced.Both devices were the same model: 00145.But they were from separate lots.It is possible that the vwing at the site that never healed was from either lot 15-0005 or from lot 15-0029.Lot 15-0005 was manufactured on 25 jan 2015, with an expiration date of january 2020.Lot 15-0029 was manufactured on 03 mar 2015, with an expiration date of february 2020.Initially submitted to fda on 05 march 2016 as 2009273792-2016-00003, instead of 3009273792-2016-00003.Amended report with correct fei number (b)(4) submitted on 24 march 2016.
 
Event Description
Patient (b)(6) was implanted on (b)(6) 2016 with two devices.He presented to the office with what appeared to be a necrosed and infected surgical incision and pocket exposing his venous vwing device.Cannulation had never been attempted both vwings were well adhered to the vessel.Dehiscence was observed at the venous vwing site following implantation.All cultures were negative.Patient (b)(6) had a history of poor-healing skin.The reason for placing vwings had been to avoid a long superficialization incision because of the pre-existing skin healing condition.Implanting surgeon stated that patient "just had crappy skin." fistula was abandoned and both vwing devices were explanted on (b)(6) 2016, and replaced with a vein graft.The open vwing site was left open and packed with saline dressing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VWING VASCULAR NEEDLE GUIDE
Type of Device
VWING
Manufacturer (Section D)
VITAL ACCESS CORP.
448 e. winchester st.
suite 250
salt lake city UT 84107
Manufacturer (Section G)
VITAL ACCESS CORP.
448 e. winchester st.
suite 250
salt lake city UT 84107
Manufacturer Contact
mark crawford
448 e. winchester st.
suite 250
salt lake city, UT 84107
8014339390
MDR Report Key5522385
MDR Text Key41027233
Report Number3009273792-2016-00003
Device Sequence Number1
Product Code PFH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K130873
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 03/05/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/24/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model Number00145
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/05/2016
Was Device Evaluated by Manufacturer? No
Date Device Manufactured01/25/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention; Disability;
Patient Age51 YR
Patient Weight105
-
-